NCT06271187 Dynamic-orthosis Programs for Stroke Hand Function
| NCT ID | NCT06271187 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Cheng-Kung University Hospital |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-01-22 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-01-22 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the training benefits of modular 3D printed dynamic orthoses on upper limb function in stroke survivors.
Eligibility Criteria
Inclusion criteria: 1. Onset of stroke at least three months ago; 2. Upper limb Brunnstrom stage II\~IV; 3. Shoulder can actively flex at least 45 degrees. Exclusion criteria: 1. Affected hand has regained autonomous grasping function, able to grasp and release a tennis ball 10 times within 2 minutes; 2. Joint deformity or stiffness in the affected hand that prevents the use of the dynamic orthosis; 3. Diagnosis of other neurological disorders affecting motor control, such as neglect, Parkinson's disease, etc.; 4. Inability to follow therapist guidance; 5. Currently undergoing other specific treatments affecting motor function recovery (such as rTMS and BTX).
Contact & Investigator
JERHAO CHANG, PhD
PRINCIPAL INVESTIGATOR
National Cheng Kung University
Frequently Asked Questions
Who can join the NCT06271187 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06271187 currently recruiting?
Yes, NCT06271187 is actively recruiting participants. Contact the research team at jerhao@ncku.edu.tw for enrollment information.
Where is the NCT06271187 trial being conducted?
This trial is being conducted at Tainan, Taiwan.
Who is sponsoring the NCT06271187 clinical trial?
NCT06271187 is sponsored by National Cheng-Kung University Hospital. The principal investigator is JERHAO CHANG, PhD at National Cheng Kung University. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.